"韧"的特性愈发凸显。放眼全球，我国经济增速在主要经济体中名列前茅，是全球经济增长最稳定、最 可靠的动力源，对世界经济增长的贡献率预计达到30%左右。稳外贸多样化格局加速形成，目前我国已 成为150多个国家和地区的主要贸易伙伴，高技术、高附加值产品成为出口增长主力，外贸展现强大韧 性。2025年高技术产品出口额比上年增长13.2%。 "进"的步伐更加有力。2025年规模以上高技术制造业增加值占规模以上工业增加值比重升到了17.1%。 民营经济促进法正式施行，综合整治"内卷式"竞争成效显现。海南自由贸易港启动全岛封关运作。2025 年，我国货物进出口总额比上年增长3.8%。民生保障有力有效，居民人均可支配收入实际增长5.0%， 与经济增长同步。养老、育幼、医疗等民生事业取得积极进展。 "新"的动能培育壮大。2025年，我国研发经费投入强度达2.8%，比上年提高0.11个百分点，首次超过 OECD国家平均水平，创新指数排名首次进入全球前十。我国在人工智能、量子科技、脑机接口等前沿 领域捷报频传。2025年，规模以上数字产品制造业增加值比上年增长9.3%，服务器、工业机器人产量 高速增长；绿电、绿能、绿色经济蓬勃发 ...

Core Viewpoint - The recent proactive cooling measures in the market aim to mitigate potential short-term severe consequences of an overheated market while maintaining a positive long-term outlook [1] Industry Analysis - The proactive cooling does not affect the overall pattern of the year-end market, but it may alleviate previously overheated conditions, leading to changes in trading directions [1] - Key sectors showing significant growth catalysts include AI computing power, non-ferrous metals, innovative pharmaceuticals, and the automotive industry [1] - Previous market hotspots such as commercial aerospace and AI applications may undergo phase adjustments, prompting attention to other thematic areas like ultra-high voltage, brain-computer interfaces, and controllable nuclear fusion [1]

Investment Rating - The investment rating for the pharmaceutical industry is "Positive" (maintained) [4] Core Viewpoints - The US tumor gene testing industry is accelerating, and there are positive domestic opportunities. The market for gene testing has low penetration rates but high growth potential, particularly in colorectal cancer early screening, treatment selection, and minimal residual disease (MRD) testing, which are all billion-dollar markets [3][8] - The report emphasizes the importance of innovation in the pharmaceutical sector, highlighting that the Chinese pharmaceutical industry has completed a transition from old to new growth drivers, particularly in innovative drugs. Companies like Heng Rui Medicine and Han Sen Pharmaceutical have made significant strides in innovation [5][41] - The report suggests that the aging population and the increasing demand for healthcare services will continue to drive growth in the pharmaceutical industry, supported by a multi-layered payment system and advancements in technology such as AI and brain-computer interfaces [41][42] Summary by Sections Market Performance - From January 12 to January 16, the pharmaceutical index fell by 0.68%, with 202 stocks rising and 261 falling. The top gainers included Baolait (up 48.76%) and Hualan Biological (up 32.72%), while the biggest losers were Sunflower (down 37.48%) and *ST Changyao (down 33.33%) [5][25][27] Gene Testing Industry - The report highlights the rapid development of the US tumor gene testing industry, with companies like Natera and Guardant Health showing impressive revenue growth. Natera's Q4 2025 revenue reached $660 million, a 39% year-on-year increase, while Guardant Health's revenue for the same period was $280 million, also up 39% [8][9] - The report notes that the domestic gene testing market is expected to grow rapidly, with companies like BGI and Edan Diagnostics actively positioning themselves in the MRD and early screening sectors [24][22] Investment Recommendations - The report recommends focusing on strong fundamentals and undervalued stocks in the innovative drug sector, including companies like Xinyi Tai, Zecjin Pharmaceutical, and Shanghai Yizhong. It also suggests monitoring emerging technologies in healthcare, such as AI and brain-computer interfaces, which are expected to see significant advancements in 2026 [5][45][44] - Specific investment combinations for January include Xinyi Tai, China Biologic Products, and Sanofi Pharmaceutical, among others [45]

第三是"新"的动能培育壮大。这一年，我国经济展现出"向新而行"的鲜明特征。2025年，研发经费投入强度达 2.8%，比上年提高0.11个百分点，首次超过OECD国家平均水平。世界知识产权组织数据显示，我国创新指数 排名首次进入全球前十。从基础研究的新探索到关键技术的新突破，从科技创新与产业创新的深度融合到惠 民成果的广泛落地，我国在人工智能、量子科技、脑机接口等前沿领域捷报频传，一批重大科研成果竞相涌 现，新质生产力不断发展壮大。2025年，规模以上数字产品制造业增加值比上年增长9.3%，服务器、工业机 器人产量高速增长；绿电、绿能、绿色经济蓬勃发展，新能源汽车国内新车销量占比超过50%。 【大河财立方消息】1月19日，国新办就2025年国民经济运行情况举行新闻发布会。 国家统计局局长康义会上表示，对于过去一年的经济表现，可以用"稳、进、新、韧"这四个字来作简要概括。 首先是"稳"的格局得到巩固。2025年的中国经济，"稳"是突出的特点。面对外部环境急剧变化，国内困难挑战 增多的复杂严峻形势，我国实施更加积极有为的宏观政策，不仅有效化解外部环境变化的不利影响，更在风 浪中稳住了发展的底盘、巩固了发展的根基。2 ...

Core Viewpoint - The performance of China's economy in the past year can be summarized with four key terms: "stability," "progress," "new," and "resilience" [1] Group 1: Stability - The stability of China's economic structure has been consolidated, with GDP expected to reach 140 trillion yuan in 2025, marking a 5.0% increase from the previous year [1] - The average urban unemployment rate is projected to be 5.2%, indicating overall employment stability [1] - The total value of goods trade has reached a new high, with foreign exchange reserves exceeding 3.3 trillion USD [1] Group 2: Progress - Despite complex internal and external environments, China is committed to high-quality development, accelerating the transformation of old and new growth drivers [2] - The proportion of high-tech manufacturing value added to total industrial value added is expected to rise to 17.1% in 2025, with final consumption contributing over 50% to economic growth [2] - The implementation of the Private Economy Promotion Law and the deepening of reform and opening-up have shown positive results [2] - The total value of imports and exports is projected to grow by 3.8% compared to the previous year [2] - Real disposable income per capita is expected to increase by 5.0%, aligning with economic growth [2] Group 3: New Dynamics - China's economy is characterized by a strong focus on innovation, with R&D expenditure intensity reaching 2.8%, surpassing the OECD average for the first time [3] - The country has entered the top ten in the global innovation index, with significant advancements in artificial intelligence, quantum technology, and other cutting-edge fields [3] - The value added of the digital product manufacturing industry is expected to grow by 9.3%, with rapid increases in the production of servers and industrial robots [3] - The share of new energy vehicle sales in the domestic market has exceeded 50% [3] Group 4: Resilience - Despite global economic challenges, China's economy has demonstrated significant resilience, achieving both quantitative and qualitative improvements [4] - China's economic growth rate ranks among the highest among major economies, contributing approximately 30% to global economic growth [4] - The export value of high-tech products is projected to increase by 13.2% compared to the previous year, showcasing strong resilience in foreign trade [4]

Core Viewpoint - The adjustment of financing margin from 100% to 80% by the three major exchanges in August 2023 laid the foundation for a liquidity bull market a year later, with significant market participation observed in early 2026 [2]. Market Reaction - On January 14, 2026, the financing margin was raised back to 100%, leading to a sharp market adjustment, with the Shanghai and Shenzhen 300 index erasing early gains and closing down by 0.40% [2]. - The market's "V-shaped" fluctuation indicates a struggle between exuberant sentiment and rational regulation, with the regulatory intent being to conduct necessary "counter-cyclical adjustments" in response to signs of overheating [2]. Financing Margin Adjustment History - The last increase in financing margin occurred on November 14, 2015, during a period of market rebound after a leveraged bull market bubble burst, with significant increases in financing balance and trading activity [5]. - In October 2015, the financing balance increased by 126.1 billion, with daily financing buy amounts rising by 76% compared to September, prompting regulatory concerns about excessive leverage [5]. Impact on Market Liquidity - The increase in financing margin is expected to suppress market trading volume, as seen in late 2015 when trading volumes returned to previous average levels despite slight index gains [8]. - The theoretical reduction in financing purchasing power by 20% will lead to a decrease in new leveraged funds, resulting in a structural optimization of market volume rather than a simple decline in trading activity [8]. Investment Logic - The policy aims to shift market focus from speculative trading to fundamental-based investments, emphasizing the importance of earnings certainty, valuation safety margins, and sustainable dividend capabilities [10]. - Large-cap stocks are expected to outperform as the reliance on leveraged trading diminishes, with blue-chip and dividend assets likely to rise quickly to compensate for previous underperformance [10]. Differences from Previous Adjustments - The current margin adjustment is considered more moderate compared to 2015, focusing on preemptive risk management rather than reacting to a market crisis [14]. - Despite the increase in margin, the current market is characterized by a recovery in earnings structure and confidence, with the financing balance relative to market capitalization remaining lower than in 2015 [15].

国家统计局局长康义在国务院新闻发布会上回答第一财经记者提问时表示，这一年，经济顶压前行、向 新向优发展，主要预期目标圆满实现，"十四五"胜利收官，第二个百年奋斗目标新征程实现良好开局。 对于过去一年的经济表现，康义用"稳、进、新、韧"这四个字来作简要概括。 康义介绍，首先是"稳"的格局得到巩固。2025年的中国经济，"稳"是突出的特点。面对外部环境急剧变 化，国内困难挑战增多的复杂严峻形势，我国实施更加积极有为的宏观政策，不仅有效化解外部环境变 化的不利影响，更在风浪中稳住了发展的底盘、巩固了发展的根基。 备受市场关注的中国经济年报发布。 国家统计局1月19日发布的数据显示，初步核算，全年国内生产总值1401879亿元，按不变价格计算，比 上年增长5.0%。分季度看，一季度国内生产总值同比增长5.4%，二季度增长5.2%，三季度增长4.8%， 四季度增长4.5%。 2025年，国内生产总值首次跃上140万亿元新台阶，比上年增长5.0%；城镇调查失业率平均值是5.2%， 就业保持总体稳定；货物贸易再创新高，外汇储备余额超过3.3万亿美元。对于我国这样超大体量的经 济体而言，在各种风险挑战交织的背景下，能够实现这 ...

国务院新闻办公室于2026年1月19日（星期一）上午10时举行新闻发布会。国家统计局局长康义介绍 2025年国民经济运行情况，并答记者问。 康义介绍，2025年是"十四五"规划收官之年，也是中国式现代化进程中具有重要意义的一年。这一年， 我国发展历程很不平凡，取得的成绩令人鼓舞，经济顶压前行、向新向优发展，主要预期目标圆满实 现，"十四五"胜利收官，第二个百年奋斗目标新征程实现良好开局。他表示，对于过去一年的经济表 现，可以用"稳、进、新、韧"这四个字来作简要概括。 首先是"稳"的格局得到巩固。2025年的中国经济，"稳"是突出的特点。面对外部环境急剧变化，国内困 难挑战增多的复杂严峻形势，我国实施更加积极有为的宏观政策，不仅有效化解外部环境变化的不利影 响，更在风浪中稳住了发展的底盘、巩固了发展的根基。2025年，国内生产总值首次跃上140万亿元新 台阶，比上年增长5.0%；城镇调查失业率平均值是5.2%，就业保持总体稳定；货物贸易再创新高，外 汇储备余额超过3.3万亿美元。对于我国这样超大体量的经济体而言，在各种风险挑战交织的背景下， 能够实现这样的稳定发展很不容易。 第二是"进"的步伐更加有力。这一年尽 ...

国家统计局局长康义在国务院新闻发布会上回答第一财经记者提问时表示，这一年，经济顶压前行、向新向优发展，主要预期目标圆满实现，"十 四五"胜利收官，第二个百年奋斗目标新征程实现良好开局。 2025年，我国GDP增长5.0%，其中四季度增长4.5%。 备受市场关注的中国经济年报发布。 国家统计局1月19日发布的数据显示，初步核算，全年国内生产总值1401879亿元，按不变价格计算，比上年增长5.0%。分季度看，一季度国内生 产总值同比增长5.4%，二季度增长5.2%，三季度增长4.8%，四季度增长4.5%。 第二是"进"的步伐更加有力。这一年尽管内外环境更加复杂，稳增长压力上升，但我们始终坚定不移走高质量发展道路，加快推进新旧动能转 换，推动改革开放走深走实，经济呈现向优向好的发展势头。经济结构调整优化，2025年规模以上高技术制造业增加值占规模以上工业增加值比 重升到了17.1%，最终消费支出对经济增长贡献率超过了5成。改革开放持续深化，全国统一大市场建设纵深推进，民营经济促进法正式施行，综 合整治"内卷式"竞争成效显现。 第三是"新"的动能培育壮大。这一年，我国经济展现出"向新而行"的鲜明特征。2025年，研 ...

Core Viewpoint - The brain-computer interface (BCI) technology is advancing rapidly, with significant support from government policies, clinical trials, and capital investment, positioning it as a key growth sector with potential applications across various industries [2][5][17]. Policy Support - The Chinese government has included BCI in its key development list for future industries, with concentrated policy support expected to accelerate clinical trials and market activity by 2025 [2][5]. - Local governments are establishing special funds and action plans to facilitate the development of the BCI industry, particularly in major cities like Beijing and Shanghai [5]. Clinical Advancements - By 2025, the number of clinical trials for BCI in China is projected to increase significantly, with breakthroughs in invasive, semi-invasive, and interventional technologies [5]. - The first global interventional BCI human trial has been completed, and advanced devices featuring "fully implanted, fully wireless" capabilities are being developed [5][10]. Capital Investment - In the first 11 months of 2025, there were 24 financing events in the BCI sector in China, marking a 30% year-on-year increase, supported by government funds and market capital [5][6]. - Notable financing rounds include several companies raising millions to billions in funding, indicating strong investor interest [6]. Industry Growth - The BCI sector is evolving into a trillion-yuan market, with major players like Neuralink preparing for large-scale production of devices, while domestic companies are making significant technological advancements [4][5]. - The industry is witnessing a robust influx of capital, with a strong willingness among investors to lock in shares, indicating confidence in the sector's stability and growth potential [4]. Technological Breakthroughs - BCI technology is categorized into invasive, semi-invasive, and non-invasive types, with invasive methods providing the best signal quality for capturing neural activity [7][10]. - Domestic advancements include breakthroughs in electrode arrays and decoding algorithms, achieving over 90% accuracy in Chinese character writing recognition [10]. Application Scenarios - BCI technology is being applied in various fields, including medical rehabilitation for paralysis and neurological disorders, as well as in industrial safety, aerospace, and entertainment [12][10]. - Specific applications include fatigue monitoring in industrial settings, cognitive health assessments in aerospace, and training aids in sports and education [12]. Industry Chain Opportunities - The BCI industry's growth is supported by a comprehensive supply chain, with opportunities in upstream components like electrodes and chips, midstream systems and algorithms, and downstream applications in healthcare and consumer products [13][16]. - Companies focusing on core components, clinical applications, and those with established market channels are well-positioned to benefit from the industry's expansion [16]. Investment Recommendations - Investors are advised to focus on three key areas: technology-leading companies, clinical application firms, and those with strong industry chain collaborations, as the BCI sector transitions from clinical validation to large-scale implementation [17].